Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹220Cr
Rev Gr TTM
Revenue Growth TTM
-1.39%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

HOCL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -1.2 | 16.9 | 35.4 | 7.5 | -5.7 | -59.2 | -7.4 | -11.6 | -25.3 | 176.1 | -27.7 | -10.8 |
| 177 | 154 | 177 | 190 | 183 | 83 | 175 | 191 | 173 | 177 | 143 | 151 |
Operating Profit Operating ProfitCr |
| 8.5 | -6.2 | 6.1 | -1.7 | -0.3 | -39.6 | 0.0 | -15.7 | -26.9 | -8.2 | -13.6 | -2.5 |
Other Income Other IncomeCr | -2 | 3 | 5 | 3 | 6 | 4 | 5 | -34 | 551 | 12 | 5 | 5 |
Interest Expense Interest ExpenseCr | 17 | 17 | 17 | 18 | 17 | 16 | 18 | 18 | -10 | 5 | 5 | 5 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| -2 | -23 | -2 | -18 | -12 | -36 | -14 | -79 | 523 | -7 | -18 | -4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -117.4 | -56.0 | 92.2 | -29.1 | -108.2 | -53.2 | -718.8 | -348.0 | 4,528.7 | 82.4 | -34.5 | 95.1 |
| -2.9 | -15.8 | -0.9 | -9.5 | -6.4 | -59.5 | -7.7 | -47.9 | 380.6 | -3.8 | -14.4 | -2.6 |
| -0.8 | -3.4 | -0.3 | -2.6 | -1.8 | -5.3 | 2.1 | -11.8 | 77.4 | -0.9 | -2.7 | -0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -25.0 | -19.4 | 22.7 | 57.6 | 83.0 | -35.1 | 25.3 | 4.4 | 45.6 | 11.5 | -23.9 | 7.1 |
| 308 | 266 | 336 | 449 | 484 | 390 | 388 | 433 | 625 | 705 | 622 | 645 |
Operating Profit Operating ProfitCr |
| -71.8 | -84.1 | -89.8 | -60.8 | 5.3 | -17.8 | 6.4 | 0.2 | 1.0 | -0.1 | -16.1 | -12.4 |
Other Income Other IncomeCr | 14 | 5 | 6 | 66 | 117 | 21 | 21 | 34 | 11 | 17 | 526 | 573 |
Interest Expense Interest ExpenseCr | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 6 |
Depreciation DepreciationCr | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -51 | -55 | 395 | 494 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
|
| -7.6 | 14.8 | -40.2 | 27.9 | 139.2 | -233.6 | 91.5 | -290.0 | -57.4 | -8.8 | 807.8 | 25.6 |
| -121.1 | -128.1 | -146.4 | -67.0 | 14.3 | -29.5 | -2.0 | -7.5 | -8.1 | -7.9 | 73.1 | 85.7 |
| -32.3 | -27.5 | -38.6 | -27.8 | 10.9 | -14.6 | -1.2 | -4.8 | -8.2 | -8.1 | 58.3 | 73.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 272 | 953 |
Current Liabilities Current LiabilitiesCr | 490 | 612 | 1,437 | 1,147 | 982 | 1,023 | 1,172 | 1,322 | 1,384 | 1,472 | 367 | 367 |
Non Current Liabilities Non Current LiabilitiesCr | 397 | 398 | 275 | 494 | 477 | 354 | 269 | 192 | 177 | 188 | 187 | 187 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 141 | 95 | 120 | 1,501 | 1,373 | 1,192 | 1,300 | 1,315 | 1,302 | 1,340 | 1,327 | 1,302 |
Non Current Assets Non Current AssetsCr | 151 | 131 | 1,697 | 158 | 178 | 182 | 141 | 160 | 172 | 233 | 237 | 237 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -116 | 46 | 59 | -451 | -160 | -81 | -50 | 10 | -13 | -66 | 631 |
Investing Cash Flow Investing Cash FlowCr | 0 | -6 | 0 | 343 | 112 | 164 | 8 | 11 | 7 | 56 | 10 |
Financing Cash Flow Financing Cash FlowCr | 104 | -48 | -59 | 179 | 3 | -90 | 52 | -32 | -10 | 6 | -642 |
|
Free Cash Flow Free Cash FlowCr | -116 | 40 | 59 | -109 | -53 | 75 | -49 | 10 | -14 | -67 | 624 |
| 53.4 | -24.9 | -22.9 | 240.9 | -219.1 | 83.2 | 599.7 | -30.7 | 25.1 | 118.8 | 161.3 |
CFO To EBITDA CFO To EBITDA% | 90.2 | -38.0 | -37.4 | 265.6 | -588.9 | 138.2 | -185.7 | 1,178.8 | -202.5 | 6,591.8 | -733.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 95 | 112 | 165 | 156 | 154 | 67 | 266 | 188 | 150 | 264 | 286 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | 104.3 | 0.0 | 0.0 | 0.0 | 0.7 |
Price To Sales Price To Sales | 0.5 | 0.8 | 0.9 | 0.6 | 0.3 | 0.2 | 0.6 | 0.4 | 0.2 | 0.4 | 0.5 |
Price To Book Price To Book | -0.1 | -0.1 | 1.4 | 4.5 | 1.4 | 3.9 | 8.4 | -39.4 | -3.0 | -5.1 | 0.8 |
| -3.4 | -3.7 | -3.2 | -3.4 | 22.2 | -6.7 | 20.7 | 1,003.3 | 121.6 | -846.9 | -2.8 |
Profitability Ratios Profitability Ratios |
| 40.1 | 49.7 | 62.9 | 50.7 | 45.2 | 36.4 | 50.8 | 39.0 | 30.1 | 29.3 | 21.8 |
| -71.8 | -84.1 | -89.8 | -60.8 | 5.3 | -17.8 | 6.4 | 0.2 | 1.0 | -0.1 | -16.1 |
| -121.1 | -128.1 | -146.4 | -67.0 | 14.3 | -29.5 | -2.0 | -7.5 | -8.1 | -7.9 | 73.1 |
| 31.9 | 16.2 | -35.1 | -19.6 | 22.4 | -8.9 | 9.7 | 4.1 | 2.1 | 1.8 | 80.2 |
| 25.1 | 17.6 | -217.7 | -544.2 | 66.1 | -563.3 | -26.3 | 676.8 | 101.2 | 107.5 | 115.3 |
| -74.5 | -81.6 | -14.3 | -11.3 | 4.7 | -7.1 | -0.6 | -2.2 | -3.5 | -3.5 | 25.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Hindustan Organic Chemicals Limited (**HOCL**), a Government of India Enterprise under the **Ministry of Chemicals & Fertilizers**, is a strategic manufacturer of bulk industrial chemicals. Following a period of financial distress, the company is currently executing a **Government-approved restructuring plan** designed to monetize legacy land assets, settle multi-billion rupee liabilities, and optimize its core manufacturing hub in Kochi, Kerala.
---
### **Core Manufacturing Hub: The Kochi Unit**
Following the closure of the Rasayani facility, all manufacturing operations are centralized at the **Kochi Unit**. This site serves as a critical supplier of intermediates for the pharmaceutical, agrochemical, and textile industries.
* **Primary Product Portfolio:**
* **Phenol:** Essential for resins, pharmaceuticals, and agrochemicals.
* **Acetone:** A key solvent for the pharmaceutical and adhesive sectors.
* **Hydrogen Peroxide:** Used extensively in paper, textiles, and water treatment.
* **Operational Efficiency:** The unit has demonstrated high productivity, often exceeding rated capacities.
* **Raw Material Integration:** **95%** of raw materials by value are petroleum-based (**Benzene, LPG, Furnace Oil, and Hydrogen**), sourced primarily from **BPCL** via direct pipeline, ensuring a steady supply chain.
* **New Product Streams:** The company recently initiated the manufacture of **Acetophenone** (projected revenue: **₹2.00 Crore**) and commissioned a **Tar Cracking Unit** (estimated contribution: **₹5 Crore/year**) to extract value from byproducts.
#### **Capacity Utilization Trends**
| Product | FY 2022-23 | FY 2023-24 | FY 2024-25* |
| :--- | :---: | :---: | :---: |
| **Phenol** | **93%** | **119%** | **87%** |
| **Hydrogen Peroxide** | **99%** | **101%** | **97%** |
| **Total Production (MT)** | **60,656** | **77,130** | **N/A** |
*\*Note: FY25 utilization was impacted by scheduled maintenance shutdowns and catalyst replacements.*
---
### **Strategic Restructuring & Financial Deleveraging**
HOCL has undergone a massive balance sheet transformation driven by a **March 2025** Government of India (GoI) order, which has effectively restored the company’s solvency.
* **The ₹1,351.38 Crore Debt Waiver:** The Parliament approved the waiver of GoI dues (as of Sept 2024), including:
* **₹435.86 Crore** in GoI loans.
* **₹270.00 Crore** in Redeemable Preference Shares.
* **₹645.52 Crore** in accrued and penal interest.
* **Net Worth Restoration:** This waiver resulted in an exceptional gain, swinging the company from a **₹964.34 Crore** negative net worth in FY24 to a positive **₹133.07 Crore** in FY25.
* **Capital Reduction:** To account for the preference share waiver, the company is restructuring its equity base, adjusting the paid-up capital to **67,17,31,000** equity shares at **₹10** each.
---
### **Asset Monetization & Liquidity Generation**
A central pillar of HOCL’s recovery is the sale of extensive land holdings in Maharashtra to settle liabilities and fund working capital.
* **Rasayani Land (Maharashtra):** Originally **1,012.355 acres**.
* Significant portions have been sold to **BPCL**, **ISRO**, and **IOCL**.
* **517.819 acres** remain classified as **Assets Held for Sale** with a carrying value of **₹945.5 Crore**.
* **Panvel Land:** **7.09 acres** are slated for sale with a reserve price of **₹158 Crore**.
* **Subsidiary Exit:** **Hindustan Fluorocarbons Limited (HFL)** is being formally closed. HOCL is currently delisting HFL from the **BSE** at a floor price of **₹17.76/share**. HFL is no longer a "Going Concern."
---
### **Technology Upgrades & Cost Optimization**
To combat competition from large-scale private players and imports, HOCL is investing in energy efficiency and process modernization.
* **Catalyst Transition:** Evaluating a shift from **SPA1** to **Zerolite** catalysts for Cumene production. This **₹200 Crore** investment is expected to add **₹13 Crore** to annual profits and reduce maintenance downtime by **60 days** every six years.
* **Energy Savings:**
* **LNG Transition:** Switched boiler fuel from furnace oil to **LNG**, saving **₹14 Crore** annually.
* **Power Trading:** Utilizes **open access power trading**, saving **₹1.32 Crore** in FY24.
* **Equipment:** New air compressors and IE3 motors are expected to save **₹1.87 Crore/year**.
* **Logistics Innovation:** Exploring **railway coach transport** in collaboration with **BPCL** to reduce the high cost of supplying customers in North and East India.
---
### **Risk Factors & Market Challenges**
Investors should note several critical risks that impact HOCL’s operational stability:
* **Feedstock Vulnerability:** In **March 2026**, HOCL declared **Force Majeure** and shut down Phenol/Cumene plants after **BPCL** diverted **LPG** supply to domestic consumers following a GoI directive.
* **Market Concentration:** Revenue is highly concentrated among three distributors: **Pooja Petro Chemicals (30-32%)**, **Ponpure Chemical (13-15%)**, and **Neepra Trading (12-13%)**.
* **Competitive Pressure:** Domestic private competitors are adding capacities of up to **6 lakh MT**, significantly larger than HOCL’s **40,000 MT** capacity. This forces HOCL to rely on **anti-dumping duties** and explore **export markets** for survival.
* **Legal Contingencies:**
* **Mesne Profits:** A **₹43.07 Crore** liability recognized following a Supreme Court order regarding the Harchandrai & Sons rent dispute.
* **JNPT Dispute:** A **₹33.19 Crore** demand regarding lease rent for a Liquid Tank Farm remains contested.
* **Governance:** The company has faced **BSE penalties** for non-compliance with **SEBI (LODR)** regulations, specifically regarding the lack of Independent and Woman Directors, which are subject to GoI appointment timelines.
---
### **Quality & Compliance Certifications**
HOCL maintains high industrial standards at its Kochi Unit through an **Integrated Management System (IMS)**:
* **ISO 9001:2015** (Quality) & **ISO 14001:2015** (Environment).
* **ISO 45001:2018** (Safety) & **ISO 50001:2018** (Energy).
* **BIS Certification:** All products carry Bureau of Indian Standards certification.
* **FSSAI:** The industrial canteen holds a **5-star "Eat Right Campus"** rating.